Vitamin D blood testing (25-hydroxy and 1,25-dihydroxy) — Coverage Criteria
Policy governs medical necessity and reimbursement for laboratory measurement of 25-hydroxy vitamin D (CPT 82306) and 1,25-dihydroxy vitamin D (CPT 82652) for Neighborhood Health Plan of Rhode Island members across Commercial, Medicaid (excluding EFP), and INTEGRITY lines of business.
No material clinical or coverage changes in this revision.
Medical Necessity and Coverage Rules
Trek Health ingests and normalizes Transparency in Coverage data and payer policy updates to give provider organizations a clear view of how commercial reimbursement behaves across markets, payers, and services. Our platform transforms raw payer disclosures into structured intelligence that supports contract evaluation, payer negotiations, and service line strategy. By combining market benchmarks with ongoing policy visibility, Trek helps teams identify variability, risk, and opportunity in commercial reimbursement. The result is faster insight, stronger negotiating positions, and more informed financial decisions.